Pressures of day-to-day clinical radiology can mean NHS trials and research are overlooked due to lack of capacity, says Choice Health. Pharma and clinical research organisations have set turnarounds and service level agreements; if these are breached, they may pull out of sites and run trials abroad instead. “The net effect is denying patients access […]
Read MoreChoice Health exhibited at the UKIO conference last month where it showcased its services, including newly commissioned research clinical trial imaging support for the NHS. Greenan with Intelerad Medical Systems president Morris Panner and Choice Health medical director Dr Riz Basit. “Immense pressures are placed on imaging departments, with yearly demand increasing in clinical activity,” […]
Read MoreChoice Health says: “This year the UK national Imaging and Oncology (UKIO) Conference is in our home town of Liverpool, and hence we are delighted to share our imaging expertise for NHS research, pharma and CRO clients.” NHS clinical trials and research imaging is often overlooked due to pressures of clinical reporting and subsequent the […]
Read More
